Cargando…

Comment on: Hellemons et al. Initial Angiotensin Receptor Blockade–Induced Decrease in Albuminuria Is Associated With Long-Term Renal Outcome in Type 2 Diabetic Patients With Microalbuminuria: A Post Hoc Analysis of the IRMA-2 Trial. Diabetes Care 2011;34:2078–2083

Detalles Bibliográficos
Autor principal: Davidson, Mayer B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3220841/
https://www.ncbi.nlm.nih.gov/pubmed/22110180
http://dx.doi.org/10.2337/dc11-1772
_version_ 1782217005741375488
author Davidson, Mayer B.
author_facet Davidson, Mayer B.
author_sort Davidson, Mayer B.
collection PubMed
description
format Online
Article
Text
id pubmed-3220841
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-32208412012-12-01 Comment on: Hellemons et al. Initial Angiotensin Receptor Blockade–Induced Decrease in Albuminuria Is Associated With Long-Term Renal Outcome in Type 2 Diabetic Patients With Microalbuminuria: A Post Hoc Analysis of the IRMA-2 Trial. Diabetes Care 2011;34:2078–2083 Davidson, Mayer B. Diabetes Care Diabetes Care Electronic Pages American Diabetes Association 2011-12 2011-11-14 /pmc/articles/PMC3220841/ /pubmed/22110180 http://dx.doi.org/10.2337/dc11-1772 Text en © 2011 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Diabetes Care Electronic Pages
Davidson, Mayer B.
Comment on: Hellemons et al. Initial Angiotensin Receptor Blockade–Induced Decrease in Albuminuria Is Associated With Long-Term Renal Outcome in Type 2 Diabetic Patients With Microalbuminuria: A Post Hoc Analysis of the IRMA-2 Trial. Diabetes Care 2011;34:2078–2083
title Comment on: Hellemons et al. Initial Angiotensin Receptor Blockade–Induced Decrease in Albuminuria Is Associated With Long-Term Renal Outcome in Type 2 Diabetic Patients With Microalbuminuria: A Post Hoc Analysis of the IRMA-2 Trial. Diabetes Care 2011;34:2078–2083
title_full Comment on: Hellemons et al. Initial Angiotensin Receptor Blockade–Induced Decrease in Albuminuria Is Associated With Long-Term Renal Outcome in Type 2 Diabetic Patients With Microalbuminuria: A Post Hoc Analysis of the IRMA-2 Trial. Diabetes Care 2011;34:2078–2083
title_fullStr Comment on: Hellemons et al. Initial Angiotensin Receptor Blockade–Induced Decrease in Albuminuria Is Associated With Long-Term Renal Outcome in Type 2 Diabetic Patients With Microalbuminuria: A Post Hoc Analysis of the IRMA-2 Trial. Diabetes Care 2011;34:2078–2083
title_full_unstemmed Comment on: Hellemons et al. Initial Angiotensin Receptor Blockade–Induced Decrease in Albuminuria Is Associated With Long-Term Renal Outcome in Type 2 Diabetic Patients With Microalbuminuria: A Post Hoc Analysis of the IRMA-2 Trial. Diabetes Care 2011;34:2078–2083
title_short Comment on: Hellemons et al. Initial Angiotensin Receptor Blockade–Induced Decrease in Albuminuria Is Associated With Long-Term Renal Outcome in Type 2 Diabetic Patients With Microalbuminuria: A Post Hoc Analysis of the IRMA-2 Trial. Diabetes Care 2011;34:2078–2083
title_sort comment on: hellemons et al. initial angiotensin receptor blockade–induced decrease in albuminuria is associated with long-term renal outcome in type 2 diabetic patients with microalbuminuria: a post hoc analysis of the irma-2 trial. diabetes care 2011;34:2078–2083
topic Diabetes Care Electronic Pages
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3220841/
https://www.ncbi.nlm.nih.gov/pubmed/22110180
http://dx.doi.org/10.2337/dc11-1772
work_keys_str_mv AT davidsonmayerb commentonhellemonsetalinitialangiotensinreceptorblockadeinduceddecreaseinalbuminuriaisassociatedwithlongtermrenaloutcomeintype2diabeticpatientswithmicroalbuminuriaaposthocanalysisoftheirma2trialdiabetescare20113420782083